Hyperthyroidism and pregnancy.
D013956:Antithyroid Agents / Q000494:pharmacology / Q000627:therapeutic use; D005260:Female; D005315:Fetal Diseases / Q000139:chemically induced; D005333:Fetus / Q000187:drug effects; D006111:Graves Disease; D006801:Humans; D006980:Hyperthyroidism / Q000150:complications* / Q000175:diagnosis / Q000188:drug therapy; D007231:Infant, Newborn; D007454:Iodides / Q000009:adverse effects / Q000097:blood / Q000378:metabolism / Q000494:pharmacology; D007457:Iodine Radioisotopes; D008135:Long-Acting Thyroid Stimulator / Q000494:pharmacology; D008431:Maternal-Fetal Exchange / Q000187:drug effects; D011247:Pregnancy; D011248:Pregnancy Complications; D013960:Thyroid Function Tests; D013972:Thyrotropin / Q000009:adverse effects; D013974:Thyroxine / Q000378:metabolism; D013975:Thyroxine-Binding Proteins
D013956:Antithyroid Agents; D007454:Iodides; D007457:Iodine Radioisotopes; D013975:Thyroxine-Binding Proteins; D013972:Thyrotropin; D008135:Long-Acting Thyroid Stimulator; D013974:Thyroxine